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Abstract: Simultaneous time- and wavelength-resolved fluorescence 
spectroscopy (STWRFS) was developed and tested for the dynamic 
characterization of atherosclerotic tissue ex vivo and arterial vessels in vivo. 
Autofluorescence, induced by a 337 nm, 700 ps pulsed laser, was split to 
three wavelength sub-bands using dichroic filters, with each sub-band 
coupled into a different length of optical fiber for temporal separation. 
STWRFS allows for fast recording/analysis (few microseconds) of time-
resolved fluorescence emission in these sub-bands and rapid scanning. 
Distinct compositions of excised human atherosclerotic aorta were clearly 
discriminated over scanning lengths of several centimeters based on 
fluorescence lifetime and the intensity ratio between 390 and 452 nm. 
Operation of STWRFS blood flow was further validated in pig femoral 
arteries in vivo using a single-fiber probe integrated with an ultrasound 
imaging catheter. Current results demonstrate the potential of STWRFS as a 
tool for real-time optical characterization of arterial tissue composition and 
for atherosclerosis research and diagnosis. 
©2011 Optical Society of America 
OCIS codes: (170.6510) Spectroscopy, tissue diagnostics; (300.6500) Spectroscopy, time-
resolved. 
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1. Introduction 
Fluorescence spectroscopy offers great potential for non-invasive disease diagnosis by 
analyzing the tissue autofluorescence from endogenous fluorophores [1–3]. The detection of 
cancer and atherosclerosis based on intrinsic fluorescence signals has been widely explored 
[4–17]. This optical method provides a feasible and quantitative molecular analysis at 
relatively low cost. Among a number of spectroscopic techniques, time-resolved laser-induced 
fluorescence spectroscopy (TR-LIFS) is particularly promising for clinical application 
because this modality not only exhibits a reliable characterization using multiple parameters 
such as fluorescence intensity, wavelength, and lifetime but is also minimally affected by the 
irregular tissue surface and the presence of endogenous absorbers [11–17]. Time-resolved 
fluorescence spectroscopy has developed rapidly in the past two decades and been applied to 
diagnose tissue diseases including tumors and atherosclerosis [7,11–17]. However, the current 
application of TR-LIFS is still limited by the time-consuming data acquisition and signal 
analysis and information extraction [17,18]. To overcome these challenges, we proposed a 
novel concept for simultaneous time- and wavelength-resolved fluorescence spectroscopy 
(STWRFS) [19]. This method is able to record fluorescence lifetime at multiple wavelengths 
sequentially in less than 200 ns using a single detector and light source. Further, wavelength 
selection is accomplished by inserting specific dichroic filters once the relevant wavelengths 
are determined for the particular tissue or disease. This design improves the data acquisition 
speed and reduces the complexity of the instrument. 
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The TR-LIFS devices tested in medical applications, typically include four key 
components: a picosecond pulsed laser to induce fluorescence, a monochromator for spectrum 
scanning, a photomultiplier (picosecond resolution) electronically recording and amplifying 
the emitted photons, and a fast digitizer (usually an oscilloscope with at least GHz bandwidth) 
for signal acquisition and analysis [14,15,17,18]. To differentiate fluorophores with 
overlapping spectra, fluorescence lifetime is used, as particular biomolecules can be identified 
in complex biological systems based on their temporal decay signature. Both fluorescence 
lifetime and intensity data are analyzed over a broad spectral range from ultra-violet (UV) up 
to near infrared. The analysis of these combined data (spectral intensities and lifetimes) 
provides TR-LIFS with the enhanced capability to detect specific conditions in tissues based 
on the changes in biochemical composition and metabolism [11,14,16]. However, the 
application of TR-LIFS in clinical setting is still challenging due to a number of factors 
including error caused by tissue/patient motion, variation of light intensity affected by blood 
flow in the optical pathway, and time-consuming measurements at multiple locations due to a 
single “point” readout. In contrast, a STWRFS system is able to acquire fluorescence lifetime 
data within multiple spectral bands dynamically while moving across the tissue. 
Extending our previously described system, i.e. STWRFS [19], the primary goals of this 
study were as follows: 1) to optimize and test the STWRFS system for dynamic line scanning 
of large tissue samples; and 2) to test the STWRFS as a potential tool for dynamic 
characterization of arterial vessels using intravascular catheters. Based on the STWRFS’s fast 
data acquisition time, this study evaluates the performance of dynamic time-resolved 
fluorescence measurement while linearly scanning over several centimeters of atherosclerotic 
tissues samples ex vivo, and pig arteries intravascularly under pulsatile blood flow conditions 
in vivo. Secondarily, this study tests STWRFS’s ability to work in conjunction with 
conventional ultrasonic-based tissue diagnostic scanning systems, i.e. ultrasound backscatter 
microscopy (UBM) and intravascular ultrasound (IVUS). Since the ultrasonic systems provide 
structural/morphological information about tissues they are complementary to fluorescence-
based tissue diagnostic methods such as STWRFS that primarily provide biochemical 
information. Thus this approach is important for future practical intravascular implementation 
of STWRFS. 
2. Materials and methods 
2.1 STWRFS system design and configuration 
A schematic of the STWRFS system is illustrated in Fig. 1(a), with a photograph shown in 
Fig. 1(b). The design consists of a combination of dichroic filters and different lengths of 
optical fiber. The primary concept of STWRFS was described briefly above and was reported 
in a previous letter [19], however the optics and electronics in the current system were 
modified to achieve more efficient fluorescence detection specifically for the lower signal 
levels found in biological tissue samples. First the laser delivery and fluorescence collection 
was executed through the same optical fiber, which provided a self-aligned fluorescence 
excitation and collection probe with a high optical efficiency. This also enabled the design of 
intravascular catheters in a relatively small diameter. Second, the nitrogen pulsed laser (MNL 
205, LTB Lasertechnik Berlin, Germany) used here offered a 16x higher pulse energy (at the 
fiber output), a 5x higher repetition rate, and a shorter pulse width (40% reduction) compared 
with the previous system. These parameters not only enabled a higher fluorescence signal but 
also improved the speed of data acquisition. The compact size of this laser allowed a portable 
STWRFS on a mobile cart appropriated for in vivo experiments in the animal surgery lab. In 
addition, the photo-detector and oscilloscope were upgraded to reach a higher temporal 
resolution as described later. Finally the line scanning function and the incorporation of 
ultrasound imaging allowed a multi-modal dynamic tissue characterization tool for in vivo 
application. During STWRFS experiments, tissue autofluorescence was induced using the  
337 nm laser with the pulse width of 700 ps and repetition rate up to 50 Hz. The light was 
delivered (laser excitation) and collected (fluorescence emission) via a single fused silica 
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optical fiber (NA = 0.22) with a diameter of 400 μm or 600 μm for in vivo and ex vivo 
experiments, respectively. The fluorescence was delivered to a series of 45° dichroic filters 
held in microscope filter cubes (U-MF2, Olympus), and bandpass filters (Semrock, Rochester, 
NY, USA) so that the light was split into the three sub-bands. The three filters were optimized 
for the autofluorescence characterization of artery according to our previous work [11,14,16]. 
They offered higher transmittance (>95%) and more appropriate bandwidths compared with 
those in previous setup [19]. The first filter (F1: 390/40 nm) corresponded to the peak 
emission wavelength of collagen and the second filter (F2: 452/45 nm) was designed to record 
the maximum emission of elastin with a reduced influence from collagen, seen in Fig. 2(b). 
Filter 3 (F3: 542/50 nm) was chosen to detect the autofluorescence of lipids. The signal was 
then coupled into three fibers with varying lengths of 1, 10, and 19 m (OZ Optics) using 
integrated collimation lenses. The proximal ends of the fibers were coupled to a multichannel 
plate photomultiplier (MCP-PMT, R5916U-50, Hamamatsu, Bridgewater, NJ, USA) which 
had a rise time of 180 ps. The electronic signals from the MCP-PMT were amplified by a 
preamplifier (C5594, 1.5G Hz bandwidth, Hamamatsu) and recorded by a digital oscilloscope 
(DPO7254, 2.5 GHz bandwidth, 20 GHz sampling rate, Tektronix Inc., Richardson, TX, 
USA). The acquisition was completed in less than 200 ns after one excitation laser pulse. The 
excitation energy on the sample was set at 2-2.5 μJ to produce sufficient signal but limited 
photobleaching and phototoxicity. The pulse energy at the fiber output was up to 16 μJ. To 
improve the signal to noise ratio, fluorescence profiles were averaged over 6-16 samples on 
the digitizer. The previous STWRFS required the average of 16-256 samples even for 
fluorescent dye solutions. For intravascular catheter application, a single fiber configuration 
was design to deliver excitation light and collect fluorescence emission with the same optical 
fiber. The single fiber function was built in a miniature assembly using a 30 mm cage cube 
(CW1-4E, Thorlabs, Newton, NJ, USA) containing a dichroic mirror and two SM05 tubes, 
shown in Fig. 1(a) and 1(b). Inside these tubes, 6 mm quartz lenses were used as beam 
collimators (f = 10 mm, Thorlabs, Newton, NJ, USA). Optical fibers were mounted on the 
cage system with SMA adaptors so that it was possible to exchange optical fibers feasibly. 
The whole system was deigned to be compact and flexible for clinical applications. 
2.2 Scanning function and setup 
For ex vivo tissue scanning experiments a custom-built positioning stage was used to move the 
optical fiber along the tissue sample surface. This recently reported assembly [18] was 
originally designed in our lab for bi-modal fluorescence spectroscopy and UBM studies and 
permits the acquisition of information on both tissue biochemical composition and 
structural/morphologic data. The positioning system incorporated a precise x-y-z translation 
stage (MX80L/MX80S, Parker-Daedal, Irwin, PA, USA), a stepper motor (Vix250AH/E-DC, 
Parker Hannifin, Rohnert Park, CA, USA), and a controller (ACR9000). The maximum travel 
limit was 50 mm with a positional accuracy of 1 μm. The scanning speed was set at  
1 mm/second to accommodate the repetition rate ( 50 Hz) of the nitrogen laser. For 
improved signal to noise ratio, each acquisition averaged the fluorescence from 16 laser 
pulses. For tissue samples with strong fluorescence emission the average number could be 
lowered thus enabling faster scanning speeds. For example, for an average of 6 pulses the 
scanning speed was set at 2 mm/second which resulted in a single line scanning (2 cm 
distance) in 10 s. During scanning the optical fiber probe was positioned in close proximity to 
tissue. Due to the irregular tissue surface the probe-to-tissue distance was estimated to vary 
between 0.5 and 1.5 mm. 
2.3 Biomolecules and tissue samples 
Collagen type I from bovine Achilles (C9879) and elastin from bovine neck ligament (E1625) 
were purchased from Sigma. Human aorta samples were obtained post-mortem and frozen 
within 2 hours of autopsy. They were snap-frozen by first being dipped in isopentane to 
reduce freezing artifacts and then being dipped in liquid nitrogen and stored at 80°C. The 
samples were defrosted at 4°C overnight before being spectroscopically investigated. A total 
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of four aorta samples from three patients were measured using STWRFS. In addition, 
conventional TR-LIFS measurements of diverse arterial beds similar to those we previously 
reported [11,14,16,20] were conducted at multiple points along the scanning line of STWRFS. 
Results were analyzed and compared to verify the new method. Prior to STWRFS 
measurements, the clinical pathologist identified the regions of interest (plaques of interest) in 
the excised tissue. This was based on visual inspection. STWRFS linear scanning was 
performed across these representative areas. The beginning and the end of the scanning line as 
well as distinct anatomic markers on tissue surface (e.g. protrusions, change in tissue surface 
color, capillaries, etc) were marked using tissue ink in a specified color code. Then, the tissue 
was fixed in formalin, pre-cut in a narrow piece (~2 mm thick) along the scanning line, and 
fixed in paraffin block for pathology analysis. Using a conventional microtome tissue was cut 
on 4 μm thick sections along the scanning line, mounted on the microscope slides, and stained 
with conventional H&E and trichrome. All pathology slides were prepared by a qualified 
technician based on standard protocol. Finally, the pathologist diagnosed the tissue types 
along the marked site independently without any information from spectroscopy. 
 
Fig. 1. STWRFS system with a single optical fiber as a probe for excitation delivery and 
fluorescence collection. (a) System diagram including optical design and electronic 
configuration. (b) Photograph of the portable optical setup using microscope cubes and micro-
lenses. 
2.4 In vivo pig experiments 
To test the ability of the STWRFS system to operate in an intravascular setting in conjunction 
with intravascular ultrasound (IVUS) and under blood flow conditions, catheter pullback 
experiments were performed in healthy arterial wall of three distinct juvenile Yorkshire pigs 
(40-50 kg) in three independent intravascular application of the catheter that enable for 
interrogation of 8 arterial segments. Since the fluorescence of such vessel wall is dominated 
by the emission of elastin fibers in the arterial intima [21], the fluorescence lifetime of these 
vessels is not expected to have significant variation along a particular arterial wall or from one 
animal to the other. The experiments were conducted in compliance with and under the 
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approval of the University of California Institutional Animal Care and Use Committee 
(IACUC), and the Occupational Health Program at UC Davis. A specialized multi-modality 
catheter (MMC), similar to a system we previously reported [21], was used for the acquisition 
of IVUS guided STWRFS. In brief, this includes: a) A commercial 3 Fr IVUS catheter  
(~1.1 mm diameter, SR Pro 30 MHz, Boston Scientific). b) A customized side-view optical 
fiber (RoMack, Inc., Williamsburg, VA; 400 μm core, 780 μm outer diameter) was used for 
STWRFS measurements. This was composed of a multimode fused silica fiber (NA = 0.22) 
with a 45° polished metalized mirror termination for beam deflection at 90° to the fiber axis. 
A polyimide tube surrounding the fiber formed a saline flushing channel with the flow rate of 
0.07 ml/s for blood removal. The optical fiber can be rotated and positioned independent of 
the IVUS catheter. c) A guide wire (0.014”) that can be used to push (steer) the optical fiber 
laterally into contact with the artery wall. The tip profile of MMC is less than 2.0 mm in 
diameter. During experiments pigs were anesthetized and injected with 5000 units of heparin 
to prevent blood clotting. The right femoral artery was surgically exposed and then the MMC 
was introduced into a femoral artery through a steerable sheath to an insertion distance of 
around 20 cm. STWRFS data and IVUS images were recorded simultaneously during 
experiments. 
The fluorescence signals were recorded through all three filters with the PMT gain voltage 
at around 2 kV and the laser energy at 2.5 μJ/pulse. Two sets of experiments were conducted. 
(1) The first set represents control experiments or still-mode measurements of the arterial wall 
fluorescence. In this case, the catheter was placed under IVUS guidance at distinct locations 
along the artery, pushed in contact with the artery wall and held still for a few tens of seconds 
to record a group of consecutive data sets (fluorescence decays) in the three channels (Filters 
1-3). In this test, the system was adjusted to obtain reliable signals and the instrumental 
parameters were optimized including laser energy, detector gain, pulse average number, 
acquisition speed, and saline flushing volumes. (2) The second set was recorded in scanning-
mode where the catheter was pulled back along the artery wall and scanned over a distance of 
a few centimeters. This mimicked a common procedure used by a cardiologist for the 
examination of the arterial wall during IVUS interventions. The STWRFS measurements were 
determined at pull-back speeds of 1 mm/s. Each acquisition took 0.5 to 1.0 s when the average 
number was 6 to 16 pulses/acquisition. 
2.5 Software for data acquisition, instrument control, and data processing 
A LabVIEW (National Instruments, Austin, Texas) interface was created to control the 
instrument, conduct data acquisition, and dynamically display the fluorescence intensity, 
intensity ratio between different emission sub-bands, and fluorescence lifetime. The detailed 
data analysis, numerical deconvolution of the fluorescence impulse response function (IRF) to 
remove the system response of the detector and pulsed laser, and calculation of the average 
lifetime values were conducted after experiments in a graphical user interface programmed in 
MATLAB (The MathWorks Inc, Natick, MA). In particular, the Laguerre polynomial 
deconvolution technique was employed to retrieve the fluorescence IRF [16]. This method 
enabled accurate and rapid lifetime mapping without a priori assumptions of the functional 
form of the fluorescence decay. The intensity was the integration of the fluorescence pulse 
profile (the area-under-the-curve of the time-resolved trace). This was equivalent to the 
steady-sate intensity. In addition, the intensity signals in the three sub-bands were calibrated 
based on the spectra of standard dyes. This calibration allowed the correction of the 
transmission of filters and endoscope, and the spectral response of the detector. 
3. Results and discussions 
3.1 STWRFS system verification on fluorescent biomolecules 
Endogenous fluorophores (collagen and elastin) were measured to test the system STWRFS 
performance and compared with the results obtained with a scanning TR-LIFS system 
available in the lab previously reported [16]. Fluorescence impulse response profiles were 
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recorded from collagen and elastin powders at the three wavelength sub-bands as shown in 
Fig. 2(a). Average lifetimes of collagen were retrieved as 2.94 ± 0.12 and 2.85 ± 0.17 ns after 
deconvolution for filters F1 and F2, respectively. The signal from filter F3 was too weak for 
precise lifetime evaluation. Fluorescence lifetimes of elastin for F1, F2, and F3 were  
1.72 ± 0.02, 1.81 ± 0.01, and 1.83 ± 0.03 ns, respectively. These values were in good 
agreement with those reported in the literature [1,17,18]. 
 
Fig. 2. Measurement of biomolecules elastin and collagen: (a) fluorescence decay profiles and 
intensity recorded simultaneously at three wavelengths sub-bands (F1, F2, F3) measured within 
200 ns. (b) Spectra of the same elastin and collagen samples excited by 337 nm laser measured 
with a scanning TR-LIFS device [16] and the corresponding sub-bands for F1(390/40), 
F2(452/45), and F3(542/50) nm filters. 
3.2 STWRFS scanning performance – validation on ex-vivo tissue samples 
Two representative results from scanning measurements made on ex vivo human 
atherosclerotic aorta using the STWRFS system with the fiber-optic catheter and the 
motorized stage are summarized in the following. 
Figure 3 demonstrates the scanning procedure and results from one sample of 
atherosclerotic aorta characterized by heterogeneous composition and morphology. During 
experiments, aorta tissue was opened along the artery axial direction and scanned in the 
perpendicular direction with a scan length of around 30 mm. The color photograph in Fig. 3(a) 
shows a human artery tissue with the scanned line used for the measurement marked. This 
tissue was determined to have three representative regions labeled in the picture as fibrotic 
plaque, early-stage plaque, and the surrounding normal tissue. This identification was based 
on visual inspection first and was further tested by histopathology analysis conducted by an 
independent pathologist according to a trichrome staining. Fibrotic plaque is usually 
considered to be a late stage lesion that is rich in collagen fibers, while early-stage plaques 
exhibit developing lipid and collagen accumulation [22,23]. The intensities of the three sub-
bands are plotted Fig. 3(c). During the scanning measurements, the fluorescence intensity 
fluctuated along the tissue surface. Although the intensity in the F1 channel is expected to 
vary depending on the tissue collagen content, the signal was also affected by the irregular 
morphology. Thus, the value of the intensity alone was not found reliable for tissue 
characterization. 
Further analysis of intensity ratios for distinct wavelength sub-bands and fluorescence 
decay characteristics within this sub-bands demonstrated that two sets of parameters show a 
clear association with tissue types and chemical compositions without being affected by the 
scanning and irregular morphology. These were the intensity ratio of F1 to F2 (IF1/IF2) and the 
fluorescence lifetime of F1 (τF1, 1/e decay time of fluorescence impulse response). Figure 3(d) 
demonstrates the IF1/IF2 and τF1 along the scanning line shown in Fig. 3(a). From left to right 
this scan traversed a fibrotic plaque, a normal area, and then another fibrotic plaque, which 
were independently identified based on histopathology analysis. The mean of average 
lifetimes (τF1) of the three regions were 2.77 ± 0.18, 1.84 ± 0.08, and 2.33 ± 0.04 ns, 
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respectively. In addition, the shoulder in this data next to the second peak was consistent with 
an early-stage plaque (intermediate lesion), with a lifetime of 2.57 ± 0.05 ns. It was found that 
the fluorescence lifetime increased by 51% for atherosclerotic plaque compared to the 
surrounding normal tissue. The average intensity ratios (IF1/IF2) in the three regions are  
1.26 ± 0.15, 0.67 ± 0.05, and 1.3 ± 0.14, respectively. The intensity ratio rose by 94% in late-
stage plaque in contrast to the normal tissue. The early-stage plaque has the intensity ratio at 
1.08 ± 0.03. Both IF1/IF2 and τF1 allowed clear visualization of the three regions consistent with 
the tissue types. 
 
Fig. 3. Example of dynamic scanning of aorta tissue: (a) The aorta was opened and scanned 
perpendicular to the axial direction. The different regions of tissue were marked with a color 
bar seen in (a) and (d). (b) STWRFS profiles recorded from a collagen-rich plaque region and 
the surrounding normal tissue. (c) Fluctuation of the fluorescence intensity along the scanning 
line from each filter. (d) Variation of fluorescence lifetime and intensity ratios of F1/F2 
showing the difference between normal artery and plaque areas. The data shown in (c) and (d) 
were recorded from a scan measurement crossing the whole tissue from the left to the right 
shown in (a) with a blue line. 
A second scanning measurement of a different human aorta sample is summarized in  
Fig. 4. This sample included three regions, classified as (from left to right): surrounding 
normal, early-stage fibrolipidic plaque, and fibrotic plaque with calcified necrotic core, as 
identified by histopathology results independently from the fluorescence measurement. The 
three regions were clearly discriminated by IF1/IF2 and τF1 as seen in Fig. 4(b). The average 
lifetimes (τF1) were also distinctive: 1.88 ± 0.11, 2.37 ± 0.07 and 2.74 ± 0.08 ns, respectively. 
Here the lifetime increased 46% for fibrotic plaque compared with the normal tissue. The 
average intensity ratio (IF1/IF2) also increased in the three regions from 0.75 ± 0.08, to  
1.44 ± 0.08, and then to 1.55 ± 0.32 respectively. The intensity ratio rose over 107% in the 
third stage. These trends are in agreement with our earlier publication [11,14,16,20] reporting 
on the time-resolved fluorescence characteristics of arterial beds including atherosclerotic 
aorta. 
This second aorta sample was also used to demonstrate the corroboration of fluorescence 
data with the UBM image (obtained with an unfocused single element 45 MHz transducer) 
used to visualize the tissue structural features (axial and lateral resolutions 38 and 200 μm, 
respectively) in the cross section under the scanned line, as shown in Fig. 4(c). The image 
shows the thickened intimal layer at the top of the tissue cross section that corresponds to the 
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early stage and fibrotic plaques areas. The region corresponding to the advanced fibrotic 
plaque also exhibited an increased hyperechoic region in the top layers corresponding to the 
dense collagen structure and ultrasound reflection (acoustic shadow) indicating the presence 
of a calcified necrotic core underneath the fibrotic cap. These features were also validated by 
histopathological analysis of the sample. 
 
Fig. 4. Comparison of STWRFS results with pathology analysis and ultrasound imaging:  
(a) Close-up photograph of the tissue scanned through three regions: surrounding normal, 
early-stage plaque, and fibrotic plaque. The arrow indicates the scanning direction.  
(b) Fluorescence lifetime and intensity ratio show differentiation of three regions (scan time 
~10 sec). (c) Ultrasound image of the cross section of the artery showing structural feature of 
the plaque. (d) Histopathology results (thricrome staining) used to confirmed the classification 
of normal (A-area), early-stage lipidic plaque (B-area), and fibrotic plaque (C-area) consistent 
with our interpretation of the STWRFS measurement. IT – intima layer; MD – media layer; LP 
– lipid rich area within thickened intima; FP – collagen rich area within intima; NC – necrotic 
area within intima. 
Figure 4(d) displays the representative images of three types of tissue from trichrome 
staining histopathology slides used to validate the STWRFS and UBM measurements:  
A - normal, B - early-stage plaque with intracellular lipid accumulation collagen fiber 
formation, C - fibrotic plaque with lipid core and fibrotic/calcific regions. Trichrome staining 
is a common method for differentiating structural proteins (collagen, elastin fibers), smooth 
muscle cells, and to distinguish these from the other lipidic and calcified structures in plaques. 
It can be observed that the main component in normal tissue (A-area) is elastin as depicted by 
the dark coloration lines in the media of the healthy aorta. Within the 250 μm arterial 
penetration depth estimated at 337 nm [12], the thickened intima of early stage plaque  
(B-area) contain a combination of collagen (green) and lipid-rich areas including macrophages 
and lipid components (white areas). In fibrotic plaque (C-area) the whole cross section is rich 
in collagen fibers. Part of a large necrotic cores is also visible on the button left of the tissue 
histology section. 
The fluorescence results are seen to be consistent with tissue composition because both 
intensity ratios and fluorescence lifetimes vary depending on the ratio of collagen (F1) to 
elastin (F2). The elastin was the main endogenous fluorophore in healthy artery wall while the 
composition of collagen gradually increased with the progression of atherosclerosis 
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[11,22,23]. Plaque tissue with more collagen showed a higher IF1/F2 value compared with the 
normal artery. Furthermore, τF1 was dominated by the collagen lifetime component (2.5 to  
5 ns), which was found longer than that of elastin (~1.5 ns). Therefore, the plaque showed a 
relatively long lifetime compared with normal tissue. The shorter fluorescence lifetime of 
early stage plaque (rich in collagen and lipids) relative to fibrotic plaques (primarily rich in 
collagen) denotes the contribution of short-lived fluorescent lipid components (~1 ns) to the 
overall fluorescence decay dynamics. 
3.3 STWRFS scanning performance – validation in vivo 
The scanning (catheter pullback sequence) experiments conducted intravascularly in vivo in 
swine arteries under IVUS guidance were used to evaluate the ability of the STWRFS 
apparatus to record robust fluorescence lifetime data in conditions that mimic conventional 
catheterization procedures including IVUS. The in vivo intravascular STWRFS application 
faced several challenges including the limitation on the diameter of optical probe, attenuation 
of fluorescence intensity by blood absorption, operation of the catheter in pulsatile blood flow, 
and the constraint for a rapid dynamic measurement. Therefore the requirement for light 
collection efficiency and probe positioning were much stricter than other types of application 
on open tissue surfaces. 
Representative results from the still-mode (control) measurements are displayed in  
Fig. 5(a), 5(b), and 5(c) showing the intensity, intensity ratio, and average lifetime at different 
times. Each data set was recorded over a one second time interval at the same location. The 
fluorescence intensity showed weak variation between different pulses but the intensity ratio 
and lifetime were found to be constant, as shown in Fig. 5 (a), 5(b) and 5(c). The intensity 
ratios of IF1/IF2, IF1/IF3, and IF2/IF3 were 0.42 ± 0.01, 1.49 ± 0.02, 3.57 ± 0.05, respectively. The 
average fluorescence lifetimes were 1.60 ± 0.01 ns and 1.86 ± 0.05 ns for F1 and F2, 
respectively. Due to the low intensity values with F3 it was difficult to achieve a robust 
deconvolution of the fluorescence IRF, thus lifetime values for F3 are not presented. 
Here both florescence intensity ratio and lifetime values were in a good agreement with 
fluorescence of the pig normal arterial wall that is rich in elastin [21]. Blood absorption had 
previously been investigated since it was a major concern in the optical design for the 
illumination and fluorescence collection. 337 nm light has very limited penetration depth in 
blood, which also has strong absorption at the fluorescence wavelengths under investigation. 
It is possible for these factors to cause the loss or distortion of autofluorescence signal of 
artery when measured in vivo in pulsatile blood flow. We determined that in still-mode all 
spectroscopic variables investigated here (intensities ratios and lifetimes) remained constant 
during the measurement. These results suggest that when the catheter is in contact with tissue 
the blood flow in the artery did not have an obvious effect on the autofluorescence 
measurement. It also indicates that the MMC catheter and STWRFS provide robust results at a 
very low flushing rate of 0.07-0.1 ml/s. 
Representative results from the scanning-mode experiments are depicted in Fig. 5(d), 5(e), 
and 5(f) for intensity, intensity ratio, and average lifetime at different positions along the 
artery wall. It was observed that the fluorescence intensity fluctuated significantly when the 
catheter moved along the lumen (Fig. 5(d)). This effect is most likely a result of (1) changes in 
light excitation-emission geometry due to fluctuations of the distance between the probe and 
sidewall and changes in the lumen diameter; and (2) attenuation of light intensity due to 
diffusion of blood between fiber optic tip and arterial wall. Although more robust when 
compared to intensity values, the intensity ratio values for the three filters also fluctuated 
especially for IF1/IF3 (Fig. 5(e)). Findings suggest that a ratiometric intensity measurement 
does not fully compensate for factors that affect the fluorescence intensity. The average 
intensity ratios of IF1/IF2, IF1/IF3, and IF2/IF3 are 0.49 ± 0.02, 1.76 ± 0.08, 3.58 ± 0.05, 
respectively. 
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 Fig. 5. In vivo test of STWRFS in pig femoral artery: (a), (b), and (c) are the data in still mode 
 the probe was held at the same location (~1 second) for multiple measurements. (d), (e), and 
(f) are the results from a pull-back measurement when the catheter was gently moved along the 
axial direction for 25 mm. (a) and (d) show fluorescence intensity for the three filters, (b) and 
(e) display the intensity ratios, and (c) and (f) show the lifetimes. 
The fluorescence lifetimes values for F1 and F2 were constant during pullback 
measurements (Fig. 5(f)) with values of 1.60 ± 0.03 ns and 1.82 ± 0.04 ns, respectively. The 
constant fluorescence lifetime indicated the composition of the artery wall along the lumen is 
similar, which was consistent with our expectation because the fluorescence of healthy young 
pig artery is primarily due to elastin emission as previously shown and confirmed by 
histology. Similar average fluorescence lifetime results depicting small standard deviation 
values (<0.05 ns) or intra-animal variability were obtained for each of the eight arterial 
segments linearly scanned in vivo. Moreover, the average fluorescence value (mean ± SD) for 
all independent measurements (total of 8 arterial segments) conducted in vivo in all animals 
was determined as 1.70 ± 0.16 for F1 and 1.8 ± 0.06 for F2. The larger SD value in this latter 
case is due to inter-animal mean lifetime value variability rather than intra-animal mean 
lifetime value changes. These findings also indicated that the MMC catheter and STWRFS 
when deployed in the close proximity of the vessel wall and pulled back provide robust results 
at a very low flushing rate of 0.07-0.1 ml/s during dynamic fluorescence recording. 
4. Conclusions 
This work has applied STWRFS to dynamic tissue characterization in the study of arterial 
vessel fluorescence ex vivo and in vivo. The near real-time acquisition of time-resolved 
fluorescence spectra has been approached based on the simultaneous measurement of multiple 
emissions split spatially by bandpass filters and synchronized temporally with optical fibers. 
Using this technique, the autofluorescence of large-scale specimens of human artery were 
scanned and studied to differentiate atherosclerotic plaque regions from surrounding normal 
tissue. It was found that the fluorescence intensity ratio and fluorescence lifetime at distinct 
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spectral bands (e.g. ratio of 390 nm / 452 nm; lifetime at 390 nm) were both associated with 
the presence of atherosclerotic lesions. For example, the fluorescence lifetime increased over 
46% in the regions of fibrotic plaque compared with the surrounding normal tissue. The 
changes in chemical composition of tissue were reflected in these two parameters and were 
consistent with pathological results. Also, these parameters appeared independent of changes 
in sample illumination geometry during scanning such as the tissue surface relief due to the 
presence of plaque. 
Furthermore, STWRFS has been successfully validated for the first time in vivo for the 
intravascular examination on a pull back sequence using a prototype multi-modal catheter 
combining a single-fiber optical probe, a conventional IVUS catheter, a steering wire enabling 
contact or close proximity between the fiber probe and arterial vessel, and a saline flushing 
channel for blood removal in the optical field of view. The two test modes (still and scanning) 
showed that STWRFS was able to record reliable autofluorescence signals from a healthy pig 
femoral artery in both modes. Most importantly, while the intensity measurements showed 
large fluctuations due to range of factors that affect the light intensity (e.g, illumination 
geometry, blood vessel cross-section geometry, and blood absorption), the fluorescence 
lifetime values provided a reliable way for the characterization of tissue composition 
independent of these light intensity modulating factors. 
Overall, both in vivo and ex vivo measurements demonstrate that STWRFS technique 
provides robust fluorescence lifetime data concerning the composition of the arterial wall 
under dynamic (scanning) measurement conditions. In addition, we showed that STWRFS can 
be intraluminaly applied and guided using conventional catheterization procedures and IVUS 
catheters. Moreover, experiments conducted in atherosclerotic tissue samples using the 
combined STWRFS and UBM system demonstrate that a combination of fluorescence and 
ultrasonic data enable simultaneous recording of biochemical and structural features, 
respectively. Future experiments are planned to determine the ability of the integrated 
STWRFS and IVUS systems to diagnose atherosclerotic plaques intravascularly in an 
atherosclerotic animal model. 
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